Smart Insulin Pens Market Report by Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Indication (Type 1 Diabetes, Type 2 Diabetes), Connectivity (Bluetooth, USB), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings), and Region 2025-2033

Smart Insulin Pens Market Report by Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Indication (Type 1 Diabetes, Type 2 Diabetes), Connectivity (Bluetooth, USB), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6138

Market Overview:

The global smart insulin pens market size reached USD 144.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 330.5 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 144.8 Million
Market Forecast in 2033
USD 330.5 Million
Market Growth Rate (2025-2033) 9.6%


A smart insulin pen is a reusable injector pen with a smartphone app that facilitates patients with diabetes in managing their insulin delivery efficiently. It is more affordable, easy to use, and provides helpful reminders, alerts, and reports compared to conventional insulin. It helps calculate doses of the blood sugar level, carbohydrate amounts, meal size, and active insulin. In addition, it notifies the expiration date or exceeding the temperature range of insulin to replace the cartridge timely. As a result, smart insulin pen finds extensive applications in hospitals, clinics, ambulatory surgical centers, and home care units across the globe.

Smart Insulin Pens Market Trends:

At present, the growing awareness among the masses about the benefits of smart insulin pens, such as delivering accurate half-unit doses, preventing skipped or missed doses, and tracking time and number of doses, represents one of the key factors driving the market. Besides this, there is a rise in the prevalence of diabetes due to the increasing obesity and geriatric population across the globe. This, along with the burgeoning healthcare industry, is strengthening the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce smart insulin pens with memory and timing function that provides intelligent injection for patients. They are also focusing on developing Bluetooth-connected smart insulin pens. Moreover, there is an increase in the adoption of home treatment as it is more comfortable, convenient, and personalized. This, coupled with the escalating demand for needle-free insulin delivery devices due to the rising needle stick injuries while using, handling, disassembling, or disposing of needles, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart insulin pens market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on type, usability, indication, connectivity and end user.

Breakup by Type:

  • First Generation Pens
  • Second Generation Pens
     

Breakup by Usability:

  • Prefilled
  • Reusable
     

Breakup by Indication:

Breakup by Connectivity:

  • Bluetooth
  • USB
     

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
     

Breakup by Region:

Smart Insulin Pens Market Report

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH and Ypsomed AG.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Million USD
Segment Coverage Type, Usability, Indication, Connectivity, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH and Ypsomed AG
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global smart insulin pens market was valued at USD 144.8 Million in 2024.

We expect the global smart insulin pens market to exhibit a CAGR of 9.6% during 2025-2033.

The growing consumer awareness towards the numerous benefits associated with smart insulin pens, such as delivering accurate half-unit doses, preventing skipped or missed doses, tracking time and number of doses, etc., is primarily driving the global smart insulin pens market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of smart insulin pens by diabetic patients to manage their insulin delivery efficiently and reduce the need for hospitalization.

Based on the type, the global smart insulin pens market can be categorized into first generation pens and second generation pens. Currently, first generation pens hold the majority of the total market share.

Based on the usability, the global smart insulin pens market has been segregated into prefilled and reusable, where reusable currently exhibits a clear dominance in the market. 

Based on the end user, the global smart insulin pens market can be bifurcated into hospitals and clinics, ambulatory surgical centers, and home care settings. Currently, hospitals and clinics account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.

Some of the major players in the global smart insulin pens market include Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH, and Ypsomed AG.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Smart Insulin Pens Market Report by Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Indication (Type 1 Diabetes, Type 2 Diabetes), Connectivity (Bluetooth, USB), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials